Skip to content

Therapeutic Exercise and Education in Pain Neurophysiology to Improve Pain Intensity in Women With Endometriosis. Clinical Trial.

Therapeutic Exercise and Education in Pain Neurophysiology to Improve Pain Intensity in Women With Endometriosis. Clinical Trial.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05682235
Enrollment
40
Registered
2023-01-12
Start date
2022-12-12
Completion date
2025-03-12
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

Pain, Quality of life, Chronic pelvic pain, therapeutic exercise, pain neurophysiology, physiotherapy

Brief summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to improve pain intensity.

Detailed description

A study will be carried out whose objective is to improve the intensity of pain in women with endometriosis through a program of therapeutic exercise and education in the neurophysiology of pain. Also as secondary variables will be observed: kinesiophobia, catastrophism and impression of global improvement with treatment.

Interventions

OTHERTherapeutic exercise AND pain neurophysiology education

A program of therapeutic exercise and education in the neurophysiology of pain will be applied to the participants of the experimental group and talks on healthy habits to the placebo group participants.

OTHERSham

Talk about healthy habits

Sponsors

University of Valladolid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

the participants will not know in which treatment group they are, and the investigator in charge of carrying out the evaluation will not know to which group the subjects he evaluates belong to.

Intervention model description

Through a randomization program, participants will be assigned to the treatment group or the control group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women of reproductive age between 18 and 45 years. * Women with a medical diagnosis of endometriosis. * Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently.

Exclusion criteria

* Women who must have surgery during the study. * Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months. * Women who are pregnant or planning a pregnancy. * Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities. * Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study. * Variations in medication in the 3 months prior to the start of the study.

Design outcomes

Primary

MeasureTime frameDescription
Changes in pain perception assessed using a 100mm Visual Analogue Scale (VAS)Baseline, Up to 1 month, Up to 3 monthsThe scale will be administered by one of the researchers. Minimum value 0. Maximum value 100. Higher score = Higher level of pain. Lowe and lower scores mean a better result.

Secondary

MeasureTime frameDescription
Changes in Kinesiofobia assessed using the Tampa Scale of Kinesiofobia (TSK)Baseline, Up to 1 month, Up to 3 monthsThe scale will be administered by one of the researchers. Minimum value 11. Maximum value 44. Higher score = Higher level of kinesiophobia. Lower and lower scores mean better results.
Changes in Catastrophism assesed using the Pain Catastrophism Scale (PCS)Baseline, Up to 1 month, Up to 3 monthsThe scale will be administered by one of the researchers. Minimum value 0. Maximum value 52. Higher score = Higher level of catastrophism. Lower and lower scores mean better results.
Impression of the overall improvement obtained with the treatment ussing the Global rating of changes scale (GROC)Up to 6 monthsThe scale will be administered by one of the researchers. Minimum value -7. Maximum value 7. Higher score = Increased improvement with treatment. Lower scores = 45 / 5.000 Resultados de traducción Resultado de traducción worsening of the patient with treatment.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026